secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001104659-24-079679
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical amends asset purchase deal with Evoqua; affirms 2024 gross margin guidance of 14-16%
--------------------------------------------------------------------------------

- Amendment reduces First Deferred Payment by $322,260 to $2,177,740, payable in four quarterly installments through April 2025.
- Second Deferred Payment of $2.5M payable in four quarterly installments from July 2025 to April 2026.
- CEO reaffirmed 2024 non-GAAP gross margin guidance of 14-16% at HC Wainwright conference, correcting a prior misstatement of 13-15% that referred to gross profit dollars.
- Amendment clarifies undeliverable equipment is excluded from acquired assets and includes a release of claims related to expired inventory disposal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000110465924079679/0001104659-24-079679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000110465924079679/tm2419450d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-079679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer